Storm of soluble immune checkpoints associated with disease severity of COVID-19

MeSH terms

• Adult
• Aged
• Aged, 80 and over
• Betacoronavirus / immunology
• Betacoronavirus / pathogenicity*
• Biomarkers / blood
• COVID-19
• Coronavirus Infections / diagnosis
• Coronavirus Infections / genetics
• Coronavirus Infections / immunology*
• Coronavirus Infections / mortality
• Cytokine Release Syndrome / diagnosis
• Cytokine Release Syndrome / genetics
• Cytokine Release Syndrome / immunology*
• Cytokine Release Syndrome / mortality
• Disease Progression
• Female
• Gene Expression Regulation / immunology*
• Hepatitis A Virus Cellular Receptor 2 / blood
• Hepatitis A Virus Cellular Receptor 2 / genetics
• Hepatitis A Virus Cellular Receptor 2 / immunology
• Humans
• Indoleamine-Pyrrole 2,3,-Dioxygenase / blood
• Indoleamine-Pyrrole 2,3,-Dioxygenase / genetics
• Indoleamine-Pyrrole 2,3,-Dioxygenase / immunology
• Lymphocyte Count
• Lymphopenia / diagnosis
• Lymphopenia / genetics
• Lymphopenia / immunology*
• Lymphopenia / mortality
• Male
• Middle Aged
• Pandemics
• Pneumonia, Viral / diagnosis
• Pneumonia, Viral / genetics
• Pneumonia, Viral / immunology*
• Pneumonia, Viral / mortality
• Retrospective Studies
• SARS-CoV-2
• Severity of Illness Index
• Survival Analysis
• T-Lymphocytes / immunology*
• T-Lymphocytes / virology
• Tumor Necrosis Factor Receptor Superfamily, Member 7 / blood
• Tumor Necrosis Factor Receptor Superfamily, Member 7 / genetics
• Tumor Necrosis Factor Receptor Superfamily, Member 7 / immunology
• Tumor Necrosis Factor Receptor Superfamily, Member 9 / blood
• Tumor Necrosis Factor Receptor Superfamily, Member 9 / genetics
• Tumor Necrosis Factor Receptor Superfamily, Member 9 / immunology